Baseline | 3 months | 4–6 months | 7–9 months | 9–12 months | 12–24 months | ||
---|---|---|---|---|---|---|---|
ESR (mm/h) | TNF-inhibitor | 8 (3,25) | 2 (1,3.75)** | 2 (1,3)** | 7 (2,9) | 2.93 (2,6) | 5.05 (2,17.75) |
non-TNF-inhibitor | 10 (5,36) | – | 2 (2,8) | – | – | 4 (0.5,10.5) | |
CRP (mg/L) | TNF-inhibitor | 4.97 (1.83,14.5) | 1.54 (1.03,3.02)* | 1.71 (1.24,2.82)** | 4.89 (1.95,8.75) | 2.01 (1.25,4.37) | 4.21 (1.0,10.83) |
non-TNF-inhibitor | 6.85 (3.11,16.05) | – | 1.95 (1.59,5.34) | – | – | 4.72 (1.8,7.43) | |
IgA (mg/L) | TNF-inhibitor | 2.96±1.34 | 1.88±1.38 | 2.20±1.01** | 1.92±1.63 | 1.78±1.32 | 2.45±1.63 |
non-TNF-inhibitor | 3.47±1.63 | – | 1.95±1.35 | – | 1.79±2.53 | 1.47±1.48 |
*P<0.05, **P<0.01.